SIGNAL
A decentralized discovery platform for emerging therapeutic devices in ME/CFS and Long COVID
This project is built around a device lending library. Patients diagnosed with ME/CFS or Long COVID borrow promising therapeutic devices, shipped directly to their homes at no cost to them, for a 1-3 month lending period. While borrowing, participants contribute standardized longitudinal data through the Brain Inflammation Collaborative/Solve ME unhide® Solve Together platform. This allows each lending cycle to be a real-world research opportunity.
​​
​
SIGNAL will address three unmet needs in the ME/CFS and Long COVID community:
-
Generate real-world evidence on patients' responses to promising therapeutic devices, with a focus on identifying patient subgroups for which each treatment is most effective.
-
Improve patient access by offering a "try before you buy" device lending library, so that expensive devices that might help are no longer out of reach.
-
Share findings quickly with the community, not just in academic papers years from now. Share accessible reports that tell patients which devices show promise, for whom, and for which symptoms.
​
Patients interested in participating in the SIGNAL study and device lending library can sign up and follow along as SIGNAL launches here:
​​​

Vielight Neuro Gamma
(Photobiomodulation)
Transcranial + intranasal near-infrared light (810 nm, 40 Hz gamma). Light penetrates a few centimeters into the brain tissue.
Truvaga
(Cervical Vagus Nerve Stimulation)
Handheld, non-invasive vagus nerve stimulation held to the neck.






